期刊文献+

Effect of acupuncture on serum PYY and nesfatin-1 in obese patients with insulin resistance 被引量:1

针刺对肥胖伴胰岛素抵抗患者血清PYY和nesfatin-1的影响
原文传递
导出
摘要 Objective To observe the effect of acupuncture on serum peptide YY(PYY)and nesfatin-1 in obese patients with insulin resistance.Methods Ninety-eight obese patients with insulin resistance were divided into a control group and an observation group by the random number table method,with 49 cases in each group.The control group received exercise and dietary interventions,and the observation group received additional acupuncture treatment to the exercise and dietary interventions.The body mass index(BMI),body fat percentage,fasting insulin(FINS),fasting plasma glucose(FPG),homeostasis model assessment for insulin resistance(HOMA-IR),triglyceride(TG),total cholesterol(TC),and serum PYY and nesfatin-1 levels were compared before and after treatment.The efficacy was evaluated after treatment.Results The total effective rate was significantly higher in the observation group than in the control group(P<0.05).After treatment,the BMI,body fat percentage,and serum TG and TC levels decreased significantly in both groups(P<0.05),and were significantly lower in the observation group than those in the control group(P<0.05).The FINS,FPG,HOMA-IR,and serum PYY and nesfatin-1 levels of the control group were not significantly changed after treatment(P>0.05).The FINS,FPG and HOMA-IR of the observation group decreased significantly after treatment(P<0.05),and were lower than those in the control group(P<0.05).The serum PYY and nesfatin-1 levels of the observation group increased significantly after treatment(P<0.05),and were higher than those in the control group(P<0.05).Conclusion Based on exercise and dietary interventions,acupuncture is effective for obese patients with insulin resistance.It can reduce the BMI,body fat percentage,blood lipids,blood glucose,and serum insulin levels and improve insulin resistance.The action may be associated with the up-regulation of serum PYY and nesfatin-1. 目的观察针刺对肥胖伴胰岛素抵抗患者血清酪酪肽(PYY)和nesfatin-1的影响。方法将98例肥胖伴胰岛素抵抗患者按随机数字表法分为对照组及观察组,每组49例。对照组予运动和饮食干预,观察组在对照组干预基础上加用针刺治疗。比较两组治疗前后的体质量指数(BMI)、体脂率、空腹血清胰岛素(FINS)、空腹血糖(FPG)、胰岛素抵抗指数(HOMA-IR),以及血清甘油三酯(TG)、总胆固醇(TC)、PYY和nesfatin-1水平,并评价其疗效。结果观察组有效率高于对照组(P<0.05)。治疗后,两组BMI、体脂率、血清TG及TC水平均降低,与本组治疗前比较差异均有统计学意义(P<0.05),且观察组低于对照组(P<0.05)。对照组治疗后FINS、FPG、HOMA-IR、血清PYY和nesfatin-1水平较治疗前比较差异无统计学意义(P>0.05)。观察组治疗后FINS、FPG和HOMA-IR均较治疗前降低(P<0.05),且低于对照组(P<0.05);观察组治疗后血清PYY和nesfatin-1水平均升高(P<0.05),且高于对照组(P<0.05)。结论在运动及饮食干预基础上加用针刺治疗肥胖伴胰岛素抵抗疗效肯定,可降低患者的BMI、体脂率及血脂、血糖和血清胰岛素水平,改善胰岛素抵抗。这可能与其提升患者血清PYY和nesfatin-1水平有关。
作者 Liu Mei-zhang Liu Yong-tao Yang Li-bai 刘美章;刘永涛;杨礼白(Huai'an Hospital of Traditional Chinese Medicine,Jiangsu Province,Huai'an 223001,China)
出处 《Journal of Acupuncture and Tuina Science》 CSCD 2021年第6期432-437,共6页 针灸推拿医学(英文版)
关键词 Acupuncture Therapy OBESITY Diet Reducing Insulin Resistance Body Mass Index Peptide YY NESFATIN-1 针刺疗法 肥胖 膳食,减重 胰岛素抵抗 体质量指数 酪酪肽 摄食抑制因子-1
  • 相关文献

参考文献2

二级参考文献28

  • 1丁宁,张梅,张琳丽,张艳慧.脂代谢紊乱的中医药研究进展[J].中国老年学杂志,2015,35(2):549-552. 被引量:17
  • 2潘艳伶,凌湘力.耳针对糖尿病脂代谢紊乱大鼠载脂蛋白及胰岛素敏感指数的影响[J].贵阳中医学院学报,2007,29(5):14-16. 被引量:6
  • 3Ahren BO. GLP-1 for type 2 diabetes[J].Experimental Cell Research,2011.1239-1243.
  • 4Ukkola OH,Puurunen VP,Piira OP. High serum fasting peptide YY (3-36) is associated with obesity-associated insulin resistance and type 2 diabetes[J].Regulatory Peptides,2011,(1-3):38-42.
  • 5Nakazato M,Murakami N,Date Y. A role for ghrelin in the central regulation of feeding[J].Nature,2001,(6817):194-198.
  • 6Gautier JF,Choukem SP,Girard J. Physiology of incretins (GIP and GLP-1) and abnormalities in type 2 diabetes[J].Diabetes & Metabolism,2008.S65-S72.
  • 7Laakso M,Zilinskaite J,Hansen T. Insulin sensitivity,insulin release and glucagon-like peptide-1 levels in persons with impaired fasting glucose and/or impaired glucose tolerance in the impaired glucose EUGENE2 study[J].Diabetologia,2008,(51):502-511.
  • 8Boeya D,Heilbronnb L,Sainsburya A. Low serum PYY is linked to insulin resistance in first-degree relatives of subjects with type 2 diabetes[J].Neuropeptides,2006,(05):317-324.doi:10.1016/j.npep.2006.08.002.
  • 9Vrang N,Madsen AN,Tang-Christensen M. PYY3-36 reduces food intake and body-weight and improves insulin sensitivity in rodent models of diet-induced obesity[J].American Journal of Physiology-Regulatory Integrative and Comparative Physiology,2006,(02):R367-R375.
  • 10Adrian TE,Ferri GL,Bacarese-Hamihon AJ. Human distribution and release of a putative new gut hormone,peptide YY[J].Gastroenterology,1985,(05):1070-1077.

共引文献38

同被引文献10

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部